Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 356-364

  Campagna, Filomena ^a   Martino, Francesco ^a   Bifolco, Maura ^a   Montali, Anna ^a   Martino, Eliana ^a   Morrone, Francesco ^a   Antonini, Roberto ^a   Cantafora, Alfredo ^b   Verna, Roberto ^a   Arca, Marcello ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Children; Familial hypercholesterolemia; Genetics; Hyperlipidemia; LDL receptor gene

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALLELE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DNA SCREENING; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; GENE MUTATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GENETIC SCREENING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; ITALY; MALE; MASS SCREENING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LDL; REFERENCE VALUES;

EID: 38049156050     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.015     Document Type: Article

References (40)

1. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York 2863-2913
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Mabuchi H., Koizumi J., Shimizu M., and Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation 79 (1989) 225-232
4. Ferrière J., Lambert J., Lussier-Cacan S., and Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor mutation. Circulation 92 (1995) 290-295
5. Hopkins P., Stephenson S., Wu L., et al. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 87 (2001) 547-553
6. Kane J.P., Malloy M.J., Ports T.A., et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimen. JAMA 264 (1990) 3007-3012
7. Smilde T.J., van Wissen S., Wollersheim H., et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomized, double-blind trial. Lancet 357 (2001) 577-581
8. Wiegman A., Hutten B.A., de Groot E., et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia. A randomised controlled trial. JAMA 292 (2004) 331-337
9. Rodenburg J., Vissers M.N., Wiegman A., et al. Familial hypercholesterolemia in children. Curr Opin Lipidol 15 (2004) 405-411
10. Civiera F. International panel on management of familial hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173 (2004) 55-68
11. Ward A.J., O'Kane M., Nicholls D.P., et al. A single base deletion in the LDLR gene (211 delG): effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, Apo-E and Apo-B genes. Atherosclerosis 120 (1996) 83-91
12. Kwiterovich Jr. P.O., Fredrickson D.S., and Levy R.I. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia) a study of its biochemical, genetic, and clinical presentation in childhood. J Clin Invest 53 (1974) 1237-1249
13. Leren T.P. Cascade genetic screening for familial hypercholesterolemia. Clin Genet 66 (2004) 483-487
14. Humphries S.E., Galton D., and Nicholls P. Genetic testing for familial hypercholesterolemia: practical and ethical issues. QJM 90 (1997) 169-181
15. Vergopoulos A., Knoblauch H., and Scuster H. DNA testing for familial hypercholesterolemia: improving disease recognition and patient care. Am J Pharmacogenomics 2 (2002) 253-262
16. Umans-Eckenhausen M.A., Sijbrands E.J., Kastelein J.J., and Defesche J.C. Low density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 106 (2002) 3031-3036
17. Arca M., Ombres D., Montali A., et al. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population. Eur J Clin Invest 32 (2002) 9-15
18. Lipid research clinics population studies data book, vol 1. The prevalence study. NIH Publication No. 80-1527. Washington, DC: National Institute of Health; 1980.
19. Menotti A., Seccareccia F., Lanti M.D., and On behalf of RIFLE Project Research Group. Mean levels and distribution of some cardiovascular risk factors in Italy in the 1970s and 1980s: the Italian RIFLE Pooling Project-risk factors and life expectancy. G Ital Cardiol 25 (1995) 1539-1572
20. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16 (1988) 1215
21. Arca M., and Jokinen H. Low-density lipoprotein receptor mutations in individuals with moderate hypercholesterolemia. Atherosclerosis 136 (1998) 187-194
22. LDL receptor mutation catalogue, 2006 [http://www.ucl.ac.uk/fh, last accessed on October 2006].
23. Bertolini S., Cantafora A., Averna M., et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor negative phenotype. Arterioscler Thromb Vasc Biol 20 (2000) E41-E52
24. Assouline L., Levy E., Feoli-Fonseca J.C., Godbout C., and Lambert M. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Pediatrics 96 (1995) 239-246
25. Bétard C., Kessling A.M., Roy M., et al. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French-Canadians. Hum Genet 88 (1992) 529-536
26. Cortner J.A., Coates P.M., and Gallagher P.R. Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr 116 (1990) 514-519
27. Lapinleimu J., Nuotio I.O., Lapinleimu H., et al. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents: the STRIP Project. Atherosclerosis 160 (2002) 417-423
28. Mozas P., Castillo S., Tejedor D., et al. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in the LDLR. Hum Mutat 24 187 (2004) 200
29. Umans-Eckenhausen M.A., Defesche J.C., Sijbrands E.J., Scheerder R.L., and Kastelein J.J. Review of the first 5 years of screening for familial hypercholesterolemia in the Netherlands. Lancet 357 (2001) 165-168
30. Boren J., Ekstrom U., Agren B., Nilsson-Ehle P., and Innerarity T.L. The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 276 (2001) 9214-9218
31. Abifadel M., Varret M., Rabes J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34 (2003) 154-156
32. Bertolini S., Cassanelli R., Garuti M., et al. Analysis of LDL receptor mutations in Italian patients with homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 19 (1999) 408-418
33. Kotze M.J., Langenhoven E., Warnich L., et al. The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia. S Afr Med J 76 (1989) 399-401
34. Koivisto U.M., Viikari J.S., and Kontula K. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823 → Asp and Leu380 → His) and eight rare mutations of the LDL receptor gene. Am J Hum Genet 57 (1995) 789-797
35. Kotze M.J., de Villiers J.N., Loubser O., et al. Double mutant LDL receptor allele in a cypriot family with heterozygous familial hypercholesterolemia. Hum Genet 100 (1997) 101-103
36. Miettinen T.A., and Aro A. Comparison of clinical findings in patients with hypertriglyceridemia and familial hypercholesterolemia. Ann Clin Res 5 (1973) 1-6
37. Wiegman A., Rodenburg J., de Jongh S., et al. Family history and cardiovascular risk in familial hypercholesterolemia. Circulation 107 (2003) 1473-1478
38. Koeijvoets K.C., Wiegman A., Rodenburg J., et al. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study. Atherosclerosis 180 (2005) 93-99
39. Martino F., Martino E., Morrone F., et al. Distribution of cholesterol plasma levels in a pediatric casistic from the mountain community "Serre Calabre". Nutr Metab Cardiovasc Dis 15 Suppl. 1 (2005) S18
40. ten Asbroek A.H., de Mheen P.J., Defesche J.C., Kastelein J.J., and Gunning-Schepers L.J. Results from a family and DNA-based active identification programme for familial hypercholesterolemia. J Epidemiol Commun Health 55 (2001) 500-502